Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
zainab_abdurrahman [2021/12/30 19:07] liam | zainab_abdurrahman [2022/01/24 21:34] (current) liam [Zainab Abdurrahman] |
---|
====== Zainab Abdurrahman ====== | ====== Zainab Abdurrahman ====== |
| |
{{:drzainababdurrahman_cropped-180x180.jpeg?150 |}} | {{ :drzainababdurrahman_cropped-180x180.jpeg?150|}} |
| |
Dr. **Zainab Abdurrahman** is a member of the Drugs & Biologics Clinical Practice Guidelines Working Group of the [[Ontario COVID-19 Science Advisory Table]].((//About Us.// Ontario COVID-19 Science Advisory Table. Retrieved December 19, 2021, from https://covid19-sciencetable.ca/about/#abdurrahman-zainab)) | Dr. **Zainab Abdurrahman** is a member of the Drugs & Biologics Clinical Practice Guidelines Working Group of the [[Ontario COVID-19 Science Advisory Table]].((//About Us.// Ontario COVID-19 Science Advisory Table. Retrieved December 19, 2021, from https://covid19-sciencetable.ca/about/#abdurrahman-zainab)) |
| |
She holds positions across advisory boards, academia, and private practice while receiving funding from pharmaceutical companies with interest in the [[COVID-19]] crisis including [[Pfizer]] and [[Merck]]. | Abdurrahman holds simultaneous positions across private practice locations, academic employment, government advisory boards, vaccine task forces, non-profit organizations, medical associations, and emergency care facilities, creating a tangled web of Conflicts of Interest (COIs). Startlingly, she also has strong ties to the pharmaceutical industry that are not fully disclosed.((Sturgess, L. (2022, January 7). //COVID-19 Report #2: Zainab Abdurrahman.// COVID-19 Reports. https://covid19reports.substack.com/p/zainab-abdurrahman)) |
===== Affiliations ===== | ===== Affiliations ===== |
| |
==== Albany Medical Clinic ==== | ==== Albany Medical Clinic ==== |
| |
Abdurrahman practices medicine at [[Albany Medical Clinic]], which on December 19, 2021 instructed patients to “get boosted” with an additional COVID-19 shot when eligible due to the Omicron variant.((//Specialists.// Albany Medical Clinic. Retrieved December 19, 2021, from https://www.albanyclinic.ca/medical-staff/specialists/)) | Abdurrahman practices medicine at [[Albany Medical Clinic]], which on December 19, 2021 instructed patients to “get boosted” with an additional COVID-19 shot when eligible due to the Omicron variant.((//Specialists.// Albany Medical Clinic. Retrieved December 19, 2021, from https://www.albanyclinic.ca/medical-staff/specialists/)) Albany Medical Clinic advocates on behalf of [[COVID-19]] vaccine policies and products, offering the [[Pfizer-BioNTech]] and [[Moderna]] products to their patients.((//COVID-19 Key Resources.// (2021). Albany Medical Clinic. https://www.albanyclinic.ca/covid-19/)) |
| |
| ==== Black Physicians Association of Ontario ==== |
| |
| Abdurrahman is a member of the Black Health & Vaccine Initiative in association with BPAO ([[Black Physicians of Ontario]]).((//Understanding COVID-19 Vaccine: Making Evidence-Based Choices for Black Children and Youth.// (2021, November 9). Toronto District School Board. https://archive.ph/qLi5C)) She was a collaborator with BPAO in drafting the position statement on Black Health & the COVID 19 vaccines.((Black Health Alliance, Black Physicians’ Association of Ontario, Black Opportunity Fund, & BlackNorth Initiative. (2021). //POSITION STATEMENT BLACK HEALTH AND THE COVID-19 VACCINES.// In Black Physicians Association of Ontario. https://bpao.org/wp-content/uploads/2021/03/FINAL_BHA-BPAO-BNI-BOF-Black-Health-COVID-19-Vaccines-Position-Statement-March-12-2021_For-Release.pdf)) The BPAO received a $1,000,000.00 donation from [[Scotiabank]], [[MD Financial Management]] and the [[Canadian Medical Association]] in February 2021.((Scotiabank. (2021, February 25). //Scotiabank, MD Financial Management and the Canadian Medical Association announce $1 million to support the Black Physicians’ Association of Ontario.// Cision Newswire. https://www.newswire.ca/news-releases/scotiabank-md-financial-management-and-the-canadian-medical-association-announce-1-milli)) |
| |
==== Black Scientists’ Task Force on Vaccine Equity ==== | ==== Black Scientists’ Task Force on Vaccine Equity ==== |
| |
Abdurrahman is a member of the [[Black Scientists’ Task Force on Vaccine Equity]], which was “created to share information about COVID-19 to the Black Canadian community and address their concerns about COVID-19 related issues.”((//Black Scientists’ Task Force on Vaccine Equity.// https://www.torontoblackcovid.com/)) | Abdurrahman is a member of the Black Scientists’ Task Force on Vaccine Equity, which was created in December 2020 “to share information about COVID-19 to the Black Canadian community and address their concerns about COVID-19 related issues.”((//Black Scientists’ Task Force on Vaccine Equity.// https://www.torontoblackcovid.com/)) ((Anielska, M. (2021, February 15). //U of T professor chairs Black Scientists’ Task Force striving for equitable vaccine rollout for Black community.// The Varsity. https://thevarsity.ca/2021/02/14/u-of-t-professor-chairs-black-scientists-task-force-striving-for-equitable-vaccine-rollout-for-black-comm unity/)) It was created by the [[City of Toronto]] in partnership with the [[TAIBU Community Health Centre]] to increase vaccine uptake/combat “vaccine hesitancy” among black people of African and Caribbean origins. |
| |
| Its membership includes mostly staff of the [[University of Toronto]] and its affiliated hospitals, professional lobbyists, and experienced developers of pharmaceutical products and [[vaccines]]. They also have connections to the [[Centre for Addiction and Mental Health]] (CAMH), [[McMaster University]] and [[McMaster Children's Hospital|Children’s Hospital]], [[Sanofi]], [[Fresenius Kabi]], [[Teva Pharmaceuticals]], [[National Resilience Inc.]], [[Patheon]], [[Ceva]], [[Labstat]], [[Medicago]], [[SiO2 Materials Science]], [[Therapure BioPharma Inc.]], [[Biovectra]], [[Apotex]], [[EmpowerPharm]], [[Alphora]], [[Kisoji Biotechnology]], [[JayChem]], [[OctaPharma]], [[NucroTechnics]], [[NoNO Inc.]], [[Chemtura]], [[AIMCo]], [[Grantek]], [[Purolator]], [[Health Canada]], [[Ontario Genomics]], and the [[Ontario Ministry of Transportation]], among others.((//Our Clients.// Brevitas. Retrieved December 28, 2021, from https://www.brevitas.us/our-clients/)) ((//Meet Our Team.// Brevitas. Retrieved December 28, 2021, from https://www.brevitas.us/meet-our-team/#)) |
| |
==== Canadian Society of Allergy and Clinical Immunology ==== | ==== Canadian Society of Allergy and Clinical Immunology ==== |
Abdurrahman is Fellows in Training co-Supervisor for the [[Canadian Society of Allergy and Clinical Immunology]] (CSACI), from whom she receives funding for speakers bureau/honoraria and/or work on advisory boards.((Abdurrahman, Z. (2021, August 30). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://covid19-sciencetable.ca/wp-content/uploads/2021/02/Declaration-of-Interest_Drugs-and-Biologics-Clinical-Practice-Guidelines-Working-Group_Zainab-Abdurrahman_20210830.pdf)) | Abdurrahman is Fellows in Training co-Supervisor for the [[Canadian Society of Allergy and Clinical Immunology]] (CSACI), from whom she receives funding for speakers bureau/honoraria and/or work on advisory boards.((Abdurrahman, Z. (2021, August 30). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://covid19-sciencetable.ca/wp-content/uploads/2021/02/Declaration-of-Interest_Drugs-and-Biologics-Clinical-Practice-Guidelines-Working-Group_Zainab-Abdurrahman_20210830.pdf)) |
| |
| ==== Food Allergy Canada ==== |
| |
| Zainab has contributed to articles published by [[Food Allergy Canada]]((Abdurrahman, Z., & Upton, J. (2018, December 27). //Mythbuster: Someone who has been treated with an epinephrine auto-injector doesn’t necessarily need to go to the hospital.// Food Allergy Canada. https://foodallergycanada.ca/mythbuster-someone-who-has-been-treated-with-an-epinephrine-auto-injector-doesnt-necessarily-need-t o-go-to-the-hospital/)) ((//From the community.// (2016, November 10). Food Allergy Canada. https://archive.ph/wVYKu)) ((//Food Allergy Testing - What’s it All About?// (2016, January 3). Food Allergy Canada. https://foodallergycanada.ca/food-allergy-testing-whats-it-all-about/)) |
| |
| Food Allergy Canada received $50,000.00 CAD from the [[National Sciences and Engineering Research Council of Canada]] (NSERCC) for a Toronto, Ontario-based proposal titled "Encouraging vaccine confidence in Canadians at risk of anaphylaxis".((Natural Sciences and Engineering Research Council of Canada. (2021, July 26). //Encouraging vaccine confidence in Canada - Competition Results.// Natural Sciences and Engineering Research Council of Canada (NSERC). Retrieved November 3, 2021, from https://www.nserc-crsng.gc.ca/NSERC-CRSNG/FundingDecisions-DecisionsFinancement/2021/Vaccine_eng.asp#tphp)) |
| |
| Their corporate partners are [[pharmaceutical_companies:Bausch Health]], [[pharmaceutical_companies:Kaléo]], [[Nestlé]], [[PepsiCo]], [[pharmaceutical_companies:Pfizer]], [[Scotiabank]], [[sickkids|SickKids Foundation]], and [[TD Banking Group|TD Securities]].((//Who we work with.// Food Allergy Canada. Retrieved January 2, 2022, from https://foodallergycanada.ca/our-impact-advocacy-and-services/about-us/who-we-work-with/)) ((//Pivoting with the pandemic.// (2021). Food Allergy Canada. https://foodallergycanada.ca/wp-content/uploads/FAC-ImpactReport-2020.pdf)) |
==== McMaster University ==== | ==== McMaster University ==== |
| |
==== Ontario COVID-19 Science Advisory Table ==== | ==== Ontario COVID-19 Science Advisory Table ==== |
| |
Abdurrahman is a member of the Drugs & Biologics Clinical Practice Guidelines Working Group of the [[Ontario COVID-19 Science Advisory Table]].((//About Us.// Ontario COVID-19 Science Advisory Table. Retrieved December 19, 2021, from https://covid19-sciencetable.ca/about/#abdurrahman-zainab)) | Abdurrahman is a member of the Drugs & Biologics Clinical Practice Guidelines Working Group of the [[Ontario COVID-19 Science Advisory Table]].((//About Us.// Ontario COVID-19 Science Advisory Table. Retrieved December 19, 2021, from https://covid19-sciencetable.ca/about/#abdurrahman-zainab)) |
| |
| Despite claims of independence, Abdurrahman holds simultaneous positions across private practice locations, academic employment, government advisory boards, vaccine task forces, non-profit organizations, medical associations, and emergency care facilities, creating a tangled web of Conflicts of Interest (COIs). Startlingly, she also has strong ties to the pharmaceutical industry that are not fully disclosed. |
| This means that Abdurrahman can not contribute to an independent discussion on public health policy without risk of influence from her conflicting interests, which are primarily relationships with [[pharmaceutical_industry|pharmaceutical companies]]. |
| |
| Abdurrahman provided identical disclosure forms to the OST on February 8, May 14, and August 30, 2021. |
==== OntarioMD ==== | ==== OntarioMD ==== |
| |
Abdurrahman is the Chair for the Section of Allergy and Clinical Immunology at the [[Ontario Medical Association]] as well as a member of the OMA Civility, Diversity, and Inclusion committee. She was elected to the board in May 2021.((Abdurrahman, Z. (2021, August 30). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://covid19-sciencetable.ca/wp-content/uploads/2021/02/Declaration-of-Interest_Drugs-and-Biologics-Clinical-Practice-Guidelines-Working-Group_Zainab-Abdurrahman_20210830.pdf)) ((//Board of Directors - Zainab Abdurrahman.// Ontario Medical Association. Retrieved December 19, 2021, from https://www.oma.org/what-we-do/about-the-oma/governance/board-of-directors/#:~:text=Zainab%20Abdurrahman%2C%20MD)) | Abdurrahman is the Chair for the Section of Allergy and Clinical Immunology at the [[Ontario Medical Association]] as well as a member of the OMA Civility, Diversity, and Inclusion committee. She was elected to the board in May 2021.((Abdurrahman, Z. (2021, August 30). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://covid19-sciencetable.ca/wp-content/uploads/2021/02/Declaration-of-Interest_Drugs-and-Biologics-Clinical-Practice-Guidelines-Working-Group_Zainab-Abdurrahman_20210830.pdf)) ((//Board of Directors - Zainab Abdurrahman.// Ontario Medical Association. Retrieved December 19, 2021, from https://www.oma.org/what-we-do/about-the-oma/governance/board-of-directors/#:~:text=Zainab%20Abdurrahman%2C%20MD)) |
| |
===== Public Health Agency of Canada ===== | ==== Public Health Agency of Canada ==== |
| |
Abdurrahman conducted “contract work for the [[Public Health Agency of Canada]]” in 2005.((Abdurrahman, Z. //Zainab Abdurrahman CV.// Retrieved December 19, 2021, from https://www.drza.org/_files/ugd/31151c_79d3d18115ad40be9c62c1fa754d577a.pdf)) | Abdurrahman conducted “contract work for the [[Public Health Agency of Canada]]” in 2005.((Abdurrahman, Z. //Zainab Abdurrahman CV.// Retrieved December 19, 2021, from https://www.drza.org/_files/ugd/31151c_79d3d18115ad40be9c62c1fa754d577a.pdf)) |
| |
| ==== Q & A Allergy ==== |
| |
| Abdurrahman practices medicine at [[Q & A Allergy]] in Mississauga.((//Dr. A Discusses Allergies and the COVID 19 mRNA Vaccines on CBC.// (2020, December 17). Q & A Allergy. https://www.qandaallergy.ca/post/dr-a-discusses-allergies-and-the-covid-19-mrna-vaccines-on-cbc)) |
| |
| ==== Scarborough Health Centre ==== |
| |
| Abdurrahman practices medicine at [[Scarborough Health Centre]]. |
| |
| ==== St Joseph's Healthcare System ==== |
| |
| Abdurrahman has hospital privileges at [[St Joseph's Healthcare System]].((//CPSO - Doctor Details.// College of Physicians and Surgeons of Ontario. Retrieved December 19, 2021, from https://doctors.cpso.on.ca/DoctorDetails/Abdurrahman-Zainab-Bukola/0242305-86703)) |
| |
| ==== University of Toronto ==== |
| |
| Abdurrahman is a 2007 graduate of the [[University of Toronto]] Medical School. |
| |
===== Relationships with Pharmaceutical Companies ===== | ===== Relationships with Pharmaceutical Companies ===== |
* [[Miravo Healthcare]] (formerly [[Aralez]]) | * [[Miravo Healthcare]] (formerly [[Aralez]]) |
* [[Novartis]] | * [[Novartis]] |
* [[Pfizer]] (this was not reported in her OST disclosures or biography). | * [[pharmaceutical_companies:pfizer|Pfizer]] (this was not reported in her OST disclosures or biography). |
* Sanofi-Genzyme Covis (specialty care global business unit of [[Sanofi]], focused on rare diseases, rare blood disorders, neurology, immunology, and oncology)((//Specialty Care.// Sanofi. Retrieved December 19, 2021, from https://www.sanofi.com/en/your-health/specialty-care)) | * Sanofi-Genzyme Covis (specialty care global business unit of [[Sanofi]], focused on rare diseases, rare blood disorders, neurology, immunology, and oncology)((//Specialty Care.// Sanofi. Retrieved December 19, 2021, from https://www.sanofi.com/en/your-health/specialty-care)) |
* [[Stallergenes-Greer]] (global biopharmaceutical company headquartered in London, specializing in the diagnosis and treatment of respiratory allergies through [[immunotherapy]])((//Stallergenes Greer’s commitment during the COVID-19 pandemic.// Stallergenes Greer. Retrieved December 19, 2021, from https://www.stallergenesgreer.com/ca/stallergenes-greers-commitment-during-covid-19-pandemic)) | * [[Stallergenes-Greer]] (global biopharmaceutical company headquartered in London, specializing in the diagnosis and treatment of respiratory allergies through [[immunotherapy]])((//Stallergenes Greer’s commitment during the COVID-19 pandemic.// Stallergenes Greer. Retrieved December 19, 2021, from https://www.stallergenesgreer.com/ca/stallergenes-greers-commitment-during-covid-19-pandemic)) |
* [[https://doi.org/10.1503/cmaj.190208|Vaccine allergy]]((Chu, D. K., & Abdurrahman, Z. (2019). //Vaccine allergy.// Canadian Medical Association Journal, 191(14), E395–E395. https://doi.org/10.1503/cmaj.190208)) | * [[https://doi.org/10.1503/cmaj.190208|Vaccine allergy]]((Chu, D. K., & Abdurrahman, Z. (2019). //Vaccine allergy.// Canadian Medical Association Journal, 191(14), E395–E395. https://doi.org/10.1503/cmaj.190208)) |
| |
She reported “receiving personal fees from [[Pfizer]], outside the submitted work”. This was not reported in her OST disclosures or biography. | She reported “receiving personal fees from [[pharmaceutical_companies:pfizer|Pfizer]], outside the submitted work”. This was not reported in her OST disclosures or biography. |
| |
* [[https://doi.org/10.1186/1710-1492-9-18|Experiencing a first food allergic reaction: a survey of parent and caregiver perspectives]]((Abdurrahman, Z. B., Kastner, M., Wurman, C., Harada, L., Bantock, L., Cruickshank, H., & Waserman, S. (2013). //Experiencing a first food allergic reaction: a survey of parent and caregiver perspectives.// Allergy, Asthma & Clinical Immunology, 9(1). https://doi.org/10.1186/1710-1492-9-18)) | * [[https://doi.org/10.1186/1710-1492-9-18|Experiencing a first food allergic reaction: a survey of parent and caregiver perspectives]]((Abdurrahman, Z. B., Kastner, M., Wurman, C., Harada, L., Bantock, L., Cruickshank, H., & Waserman, S. (2013). //Experiencing a first food allergic reaction: a survey of parent and caregiver perspectives.// Allergy, Asthma & Clinical Immunology, 9(1). https://doi.org/10.1186/1710-1492-9-18)) |